Copyright 2018 Industry Dive

Take the quiz now!

Download Now

*Required Fields

Global Genes reports that therapy adherence in the rare disease space can vary from only 58 to 65 percent, a troubling statistic for our industry, and most importantly, the patients we serve. 

Manufacturers must be wondering, how well do we really know our patients and what they need? 

Take a quick three question quiz to see if your program really addresses the most pressing needs. And most importantly, find out what the leading orphan drug manufacturers are doing about it. 

How well do you really know your patients?

Does your Rare Disease Patient Services Program Pass the Test?

Fix the following errors: